Latest News

Mutant-Allele Tumor Heterogeneity (MATH) in head, neck squamous cell carcinoma patients is effective marker, along with HPV status, of improved patient outcome

Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient?s HPV status provides an effective indicator of improved patient outcome, according to research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Can you avoid hangovers after heavy drinking?

  • Borderline personality traits linked to lowered empathy

  • Confidence in parenting could help break cycle of abuse

  • Medicinal marijuana: Patients battle stigma and misunderstanding

  • CPR: It's not always a lifesaver, but it plays one on TV

  • Goth teens could be more vulnerable to depression and self-harm

  • Brain scans predict response to antipsychotic medications

  • Older adults possess important forms of expertise

  • Covert and overt forms of sexism are equally damaging to working women

  • Retinoids may increase effectiveness of targeted therapies against high-risk leukemia

  •